NCT07723248
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07723248
Title A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) (Himalayas-1)
Acronym Himalayas-1
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors ORIC Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Urology Specialists of the Carolinas - University Place RECRUITING Charlotte North Carolina 29464 United States Details
Summit Urology RECRUITING Murray Utah 84107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field